EP. 1: Comparison of Biologics to Biosimilars Versus Generics
EP. 2: The BPCIA and the Naming of Biosimilars
EP. 3: The Approval Process for Biosimilars
EP. 4: Considerations for Approving Generics Versus Biosimilars
EP. 5: Interchangeability and Postmarketing Pharmacovigilance of Biosimilars
EP. 6: Experience Prescribing Biosimilars Versus Biologics
EP. 7: The Impact of Access to Biosimilars
EP. 8: US and EU Biosimilar Pricing and Stakeholder Education
EP. 9: Formulary Approval and Challenges for Payers
EP. 10: Prescribing Biosimilars and Educating Patients and Physicians
EP. 11: The Influence of Biosimilars in Cancer Care
EP. 12: Biosimilars in the Pipeline and Disease Management
EP. 13: Outlook on the Future of Biosimilars
